Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,475.00
-125.00 (-4.81%)
At close: Mar 9, 2026

Prestige Biologics Balance Sheet

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
563.061,58229,50745,43515,38336,775
Upgrade
Short-Term Investments
----0--
Upgrade
Cash & Short-Term Investments
563.061,58229,50745,43515,38336,775
Upgrade
Cash Growth
-96.49%-94.64%-35.06%195.36%-58.17%766.97%
Upgrade
Accounts Receivable
1,261438.43389.191,07440.751,175
Upgrade
Other Receivables
6,3174,5251,265999.612,0367,077
Upgrade
Receivables
7,5794,9631,6542,0732,0778,252
Upgrade
Inventory
30,01626,90917,8056,83312,0349,697
Upgrade
Prepaid Expenses
99.94224.64222.48147.86129.0562.23
Upgrade
Other Current Assets
2,4837,1706,44615,754213.1473.2
Upgrade
Total Current Assets
40,74040,84855,63670,24229,83554,860
Upgrade
Property, Plant & Equipment
226,515228,406233,052234,435227,107149,989
Upgrade
Other Intangible Assets
1,5371,032676.961,0471,1081,791
Upgrade
Other Long-Term Assets
-05028.8228.82128.82
Upgrade
Total Assets
268,792270,286289,414305,753258,079206,768
Upgrade
Accounts Payable
5,9147,2373,048587.441,0113,328
Upgrade
Accrued Expenses
510.22504.586,6363,1491,612841.4
Upgrade
Short-Term Debt
45,77144,62736,72630,209--
Upgrade
Current Portion of Long-Term Debt
10,88914,15610,82412,91410,6046,434
Upgrade
Current Portion of Leases
44.1912.1766.1739.6898.57134.63
Upgrade
Current Unearned Revenue
263.16263.16573.03578.251,2471,100
Upgrade
Other Current Liabilities
64,18735,61734,43241,62017,97816,555
Upgrade
Total Current Liabilities
127,579102,41792,30689,09832,55228,393
Upgrade
Long-Term Debt
27,22232,666125,414116,846107,90071,428
Upgrade
Long-Term Leases
--12.176.7216.68115.25
Upgrade
Other Long-Term Liabilities
----0-0
Upgrade
Total Liabilities
154,801135,083217,732205,950140,46899,936
Upgrade
Common Stock
38,87638,87630,75130,55430,55423,603
Upgrade
Additional Paid-In Capital
341,501341,501257,963256,059256,059202,489
Upgrade
Retained Earnings
-267,120-245,907-218,437-189,063-171,084-121,366
Upgrade
Comprehensive Income & Other
732.73732.731,4062,2532,0822,105
Upgrade
Shareholders' Equity
113,990135,20371,68299,803117,611106,832
Upgrade
Total Liabilities & Equity
268,792270,286289,414305,753258,079206,768
Upgrade
Total Debt
83,92691,461173,043160,016118,61978,112
Upgrade
Net Cash (Debt)
-83,363-89,879-143,536-114,581-103,236-41,337
Upgrade
Net Cash Per Share
-1015.41-1218.84-2345.53-1953.28-1994.89-930.05
Upgrade
Filing Date Shares Outstanding
77.7577.7561.561.1161.1147.21
Upgrade
Total Common Shares Outstanding
77.7577.7561.561.1161.1147.21
Upgrade
Working Capital
-86,840-61,568-36,670-18,855-2,71626,467
Upgrade
Book Value Per Share
1466.061738.891165.541633.221924.652263.08
Upgrade
Tangible Book Value
112,453134,17171,00598,756116,504105,041
Upgrade
Tangible Book Value Per Share
1446.291725.611154.531616.081906.522225.15
Upgrade
Land
10,56510,56510,56510,56510,56510,565
Upgrade
Buildings
70,18170,18070,18070,15068,07237,381
Upgrade
Machinery
68,81159,39056,14337,72837,56622,529
Upgrade
Construction In Progress
76,28095,46390,441126,395117,13078,220
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.